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Abstract: Smartphone-based fluorescence imaging systems have the potential to provide
convenient quantitative image guidance at the point of care. However, common approaches have
required the addition of complex optical attachments, which reduce translation potential. In this
study, a simple clip-on attachment appropriate for fluorescence imaging of protoporphyrin-IX
(PpIX) in skin was designed using the built-in light source and ultrawide camera sensor of a
smartphone. Software control for image acquisition and quantitative analysis was developed
using the 10-bit video capability of the phone. Optical performance was characterized using
PpIX in liquid tissue phantoms and endogenously produced PpIX in mice and human skin. The
proposed system achieves a very compact form factor (<30 cm3 ) and can be readily fabricated
using widely available low-cost materials. The limit of detection of PpIX in optical phantoms was
<10 nM, with good signal linearity from 10 to 1000 nM (R2 >0.99). Both murine and human
skin imaging verified that in vivo PpIX fluorescence was detected within 1 hour of applying
aminolevulinic acid (ALA) gel. This ultracompact handheld system for quantification of PpIX in
skin is well-suited for dermatology clinical workflows. Due to its simplicity and form factor, the
proposed system can be readily adapted for use with other smartphone devices and fluorescence
imaging applications. Hardware design and software for the system is made freely available on
GitHub (https://github.com/optmed/CompactFluorescenceCam).
© 2021 Optical Society of America under the terms of the OSA Open Access Publishing Agreement

1.

Introduction

Quantitative fluorescence measurement has become an essential tool in a wide range of biomedical
applications and is increasingly utilized in medicine to provide image-guidance in diagnostic
and therapeutic applications [1–4]. However, to achieve reliable quantitative performance, most
fluorescence measurement systems require bulky and/or expensive instrumentation, including
external light sources, filtering components, and highly sensitive detectors.
Recently, portable and handheld fluorescence imaging systems have been achieved by leveraging
advances in mobile and embedded computing systems, including single board computers
[5–8] and smartphones [9–18]. Smartphones, in particular, have become very sophisticated
handheld optoelectronic systems that bring high-performance cameras, computing hardware, and
touchscreen interfaces altogether in a very minimal form factor. The potential to leverage these
built-in capabilities of modern smartphones has led to the development of smartphone-based
imaging systems in an increasing range of in medical applications including: quantitative reading
of point-of-care assays [19], microscopy [20], spectroscopy [21], and in vivo diagnostic imaging
[22].
One promising application for smartphone-based in vivo fluorescence imaging is non-invasive,
real-time assessment of epidermal and epithelial lesions [9–14]. In 2018, Song and Uthoff et
al. reported one of the first smartphone-based in vivo fluorescence imaging systems, which
#439342
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consisted of an Android smartphone, a case-like attachment with optical filters, a custom optical
probe providing magnified image relay from the oral cavity, and external LED light source
with battery supply [12,13]. The system was controlled by a custom Android application
and corresponding web application for cloud-based image review and automated diagnostic
classification. Autofluorescence and white light images from 170 patients undergoing diagnostic
oral examination were acquired using the system and annotated by clinical experts. Smartphonebased fluorescence imaging in conjunction with an automated convolutional neural network
classifier achieved 87% accuracy for prediction of normal versus suspicious for precancer. While
impressive, two limitations of this smartphone-based implementation are that image quality was
often suboptimal (>50% excluded after quality review) and the optical probe relied on careful
alignment of external lenses with the smartphone camera, which could also impact image quality
and translatability to other smartphone models.
In addition to autofluorescence tissue imaging, targeted fluorescence smartphone-based systems
have been developed for sensing of protoporphyrin IX (PpIX), an endogenous fluorophore that
is produced in mitochondria of cells as part of the heme synthesis pathway [23]. In the past
two decades, system design for fluorescence quantification of PpIX has taken the form of
point probe systems [24,25], imaging systems [26–28] and even diffuse tomographic systems
[29,30]. The methods to separate the emission from the excitation light vary from spectrometer
[31], to filter based cameras [26,32,33], to time-gated detection [34]. However, all of these
implementations relied on bulky, scientific grade instrumentation. More recently, two smartphonebased implementations of PpIX sensing have been reported for monitoring of photodynamic
therapy in dermal [9] and oral [10] tissues. Both systems include external LED light sources
for blue (405nm) illumination as well as a >600 nm longpass filter mounted directly in front
of the smartphone camera lens. While both systems represent a dramatic reduction in the
cost/complexity of PpIX-sensing systems, both lacked onboard image analysis routines for
real-time signal quantification and could potentially be further simplified by utilizing the native
smartphone flash as a light source.
This study aimed to design an ultracompact fluorescence imaging attachment appropriate for
imaging of PpIX in skin that overcomes the aforementioned limitations by leveraging the built-in
LED flash as a light source in conjunction with an ultrawide camera sensor to achieve a very
compact form factor. Specifically, the main goals of this work were to create and test:
• A fully passive attachment design that can be fabricated using widely available materials
and achieves good quantitative fluorescence detection.
• Software to control the smartphone camera and perform real-time signal quantification
using 10-bit video frames.
• Demonstration of real-time handheld operation of the system for in vivo detection of
ALA-induced PpIX fluorescence in pre-clinical measurements of mice and human skin.
2.
2.1.

Methods
Optical system design

The ultracompact fluorescence attachment consisted of a clip-on attachment with embedded
optical filtering components that mounts directly onto the phone’s rear camera module (Fig. 1).
The system includes a custom software application (app) that enables a video preview of the
fluorescence signal and real-time intensity quantification. The clip attachment uses only passive
optical elements and is designed for contact-based fluorescence measurement at the surface of the
skin. This section details the design and fabrication of the hardware and software of our system.
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Fig. 1. Fabrication and assembly of ultracompact fluorescence attachment to the smartphone.

2.1.1.

Phone and iOS application

The iPhone 12 Pro Max (Model MGCF3LL/A, Apple, Cupertino, USA) running iOS 14.5
was the platform used in this study. The phone’s back camera module includes three separate
sensors that operate at various magnifications. This study utilized the ultrawide camera module,
which has a 1.54mm focal length and 120° collection angle. This camera was selected for two
reasons: 1) proximity to the built-in flash and 2) relatively large field-of-view (FOV) at short
working distances. The ultrawide camera utilizes a 1/3.6” CMOS sensor with 4032 × 3024 pixels
(approximate individual pixel dimension of 1.0 micron/pixel). The camera module includes a
dual-tone LED flash with 45 mW/cm2 peak optical power, which was characterized using an
optical power meter and spectrophotometer (see Section 2.2).
A custom iOS app called “Compact Fluorescence Camera” (abbreviated as CFCam) was
developed in the Swift programming language using XCode 12.5 on a MacBook Pro running
MacOS 11.4. When started, the app displays a live feed of the ultrawide camera feed and
provides user interface controls to adjust the exposure, ISO, and intensity of the flash lighting.
Visualization 1 provides a video demonstration of these user interface controls. The flash was
configured to operate in a static ‘torch’ mode instead of dynamic ‘flash’ mode to provide constant
illumination as the device is brought into contact with various points of interest on the skin. For
real-time quantification of fluorescence signal, an average intensity calculation is performed
using a 1280 × 720 pixel 10-bit video buffer. Minimum and maximum pixel intensities for the
10-bit video buffer were found to be 1,020 and 14,320 respectively. The average intensity from
a 200 × 200 pixel square region of interest (ROI) is computed and displayed overlaid on the
video feed in the user interface. When reporting the average intensity, the app first subtracts the
minimum pixel value and rounds to the tens digit to mitigate frame-by-frame read noise. Mean
ROI intensity as reported by the CFCam app was the quantitative metric utilized for PpIX signal
quantification throughout this study. Source code for this iOS application is available on GitHub
(https://github.com/optmed/CompactFluorescenceCam).
2.1.2.

3D printed attachment

The ultracompact fluorescence smartphone attachment design consists of a monolithic 3D printed
enclosure with an internal recess to angle the built-in flash towards the camera sensor at a 1 cm
working distance. Figure 1 provides a diagram of the fabrication and assembly process. The
attachment design was created using SolidWorks 2020 (SolidWorks Corp., Waltham, MA, USA),
and models were then converted into layer-by-layer printer files using CHITUBOX (v1.7.0) with
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the following printer settings: an individual layer height of 0.05 mm; six bottom layers, each with
a 30-s exposure time; and a typical layer exposure time of 3 s. The models were printed using
an LCD-based masked stereolithography 3D printer (Phrozen Sonic Mini) with a 50-micron
axial resolution. The printer bulk material was eSUN black Standard Resin (Shenzhen eSUN
Industrial Co., Shenzhen, China). The printing resolution provided sufficient tolerance to firmly
attach the 3D printed component onto the back camera module without the need for adhesives.
Because the 3D printing resin was slightly translucent after curing, the exterior of each printed
component was painted black to improve the reflectivity of the inner light-guiding channels and
ensure ambient lighting did not affect measurements. After painting, optical filters were inset
into the attachment. Multiple versions of the attachment were fabricated to accommodate various
optical filters as well as smaller/larger sampling FOV (Fig. 2). Detailed component lists with
material costs (Dataset 1) Ref. [35] and 3D printing files (Dataset 2) for the five attachment
designs (one using glass filters and four using lighting gel filters) evaluated in this study are made
publicly available [36].

Fig. 2. Modularity in attachment design to accommodate various filter sets (a) and imaging
fields of view (b).

2.2.

Optical filter selection and characterization

The built-in LED camera flash contains two individual LEDs that are both illuminated when
controlled using the CFCam app. Peak optical power was measured by bringing the bare LED in
close contact with an optical power probe (PM200 with S120C probe, Thorlabs, New Jersey,
USA). Additionally, the optical power throughput of each attachment was estimated by bringing
the sample plane into contact with the power probe. The LED flash spectrum was measured
using a probe-based spectrometer (Ocean Optics USB2000+, Ocean Optics Inc., Florida, USA)
to determine which wavelengths could be utilized for PpIX excitation.
In order to use the built-in flash and nearby camera sensor, our filter selection constraints were
threefold: 1) sufficiently small diameter (<13mm) and thickness (<5mm) to be placed directly in
front of the smartphone flash and lens components, 2) high blocking efficiency of excitation light
(OD ≥4), and 3) appropriate cut-on and cut-off wavelengths for PpIX excitation (400-550nm)

Research Article

Vol. 12, No. 11 / 1 Nov 2021 / Biomedical Optics Express

6999

and emission bands (600-700nm) given the LED emission spectra. A set of small diameter
glass filters that met these criteria was identified and ordered directly from an optics vendor
(stock #84-081 and #15-447, Edmund Optics, Barrington, New Jersey, USA). In addition to
conventional glass filters, three lighting gel filters were also tested; these filters have a thickness of
∼0.1mm and can readily be cut to any shape [37]. For filtering of the LED flash, two blue/green
gel filter options were evaluated (stock #727 and #735, LEE Filters, Andover, England), and for
longpass filtering of PpIX fluorescence a single red gel filter option was evaluated (LEE #106).
To characterize these filters, transmission spectra of each filter were acquired using the
probe-based spectrometer and smartphone LED light source. All spectra were recorded with a
0.2 nm spectral resolution from 350 to 1000 nm. The spectrometer probe was mounted 1 cm
away from the smartphone LED and the integration fixed to 20 µs to record the unfiltered LED
spectrum. Individual filter spectra were then measured by directly inserting them in front of the
smartphone LED. To estimate blocking efficiency, spectra were also acquired for each excitation
and emission filter combination by stacking them inline and increasing the integration time to
200 ms. Filtered and unfiltered spectra were rescaled by their respective integration times and
optical density (OD) calculated as follows:
ODλ = −Log10 τλ ,

(1)

where τλ is the transmittance measured at each wavelength (λ). Blocking OD of the LED flash at
the PpIX emission peak (OD634nm ) was compared for each filter set.
2.3.

Fluorescence phantoms and sensitivity measurements

To assess the quantitative accuracy and sensitivity of the ultracompact fluorescence imaging
system, a series of liquid fluorescence phantoms containing 1% intralipid and varying amounts
of fluorophore (0.5 to 1000 nM PpIX) were measured. Phantom solutions were prepared using
the methods described by Marois et al. [38] and are briefly summarized here. The negative
control solution was 1% intralipid with no PpIX. A bulk quantity of the control solution was
prepared by diluting Intralipid 20% w/v (NDC 0338-0519-09, Frensius Kabi/Baxter Healthcare)
into 1x phosphate buffered saline to achieve 1% w/v. A small quantity of surfactant (Tween 20,
P9416-50mL, Sigma-Aldrich Inc.) was then added at 0.1% v/v to improve the photostability of
PpIX in solution. Next, powdered PpIX (P8293-1G, Sigma-Aldrich Inc.) was serially diluted 2:1
in dimethyl sulfoxide using 2 mL Eppendorf and a starting concentration of 100 µM. A fixed
volume aliquot from each serial dilution was then pipetted into 25 cm2 rectangular cell culture
flasks (COR-430168, Corning) previously filled with approximately 50 mL of the 1% intralipid
background solution. Each flask was then rocked to mix the PpIX, filled completely with the
1% intralipid solution to fill the container volume, and sealed with the flask cap. Transfer from
Eppendorf tubes and dilution into the cell culture flasks constituted a fixed dilution factor of 100.
Final PpIX concentrations of the liquid phantoms were 1000, 500, 250, 125, 62.5, 31.3, 15.6,
7.81, 3.91, 1.95, 0.977, 0.488, and 0 nM.
Measurements were acquired from each sample by taking a screen recording of the user
interface real-time intensity calculation while placing the smartphone attachment directly in
contact with the top surface of each flask. Contact was held for approximately 1-2 seconds
to ensure the real-time intensity calculation stabilized, and each measurement was repeated in
triplicate. The LED flash was set to full brightness, and the exposure time was fixed at 100
ms across all measurements. ISO speed was reduced when using glass filters to account for
differences in transmission between glass and gel filters.
Linear regression of resulting measurements was performed in GraphPad Prism 9.1 (GraphPad
Software, California, USA). Prior to linear fitting, data were rescaled to range from 0 to 1 using
the minimum and maximum intensity readings obtained using each attachment and a log-log
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transformation was then applied. For visualization of the negative control sample on the log-log
plot, a nominal value of below the lowest concentration was assigned (0.1 nM).
2.4.

Pre-clinical in vivo murine measurements

All animal procedures were carried out following a protocol approved by the Committee for
the Protection of Human Subjects, which is the Institutional Review Board (IRB) at Dartmouth
College. Skin measurements of three nude mice were taken using the blue/red gel filter attachment
with the smallest sampling FOV (5mm). The mice were athymic and fed a low-chlorophyll
diet to mitigate tissue autofluorescence. A 10% ALA hydrochloride gel (Ameluz, Biofontera
Inc., Massachusetts) was topically applied at two sites (the right leg and middle of the back) to
induce PpIX accumulation in the skin, and the left leg was used as a control site. Measurements
were taken at four time points: just prior to application (0 min) as well as 10, 60, and 180
min post-application. Mice remained anesthetized while applying the ALA gel and during
pre- and post-application measurements (0 and 10 min), but were subsequently awakened and
re-anesthetized for later measurements (60 and 180 min). Additionally, mice were kept in a dark
environment in-between measurements to prevent photobleaching of the accumulated PpIX.
Camera acquisition settings remained fixed throughout all measurements with full LED
brightness, 100 ms exposure, and 2300 ISO speed. For each measurement, the smartphone
attachment was brought directly into contact with the skin and held for 1-2 s to allow the real-time
intensity calculation to stabilize. Measurements were repeated three times at each site and at
each time point. The maximum intensity reading across repeated measurements at each time was
recorded and used to analyze fluorescence accumulation over time. Differences in mean intensity
between the right and left legs at each time point were compared using a paired t-test (with
p<0.05 considered statistically significant). Widefield fluorescence images were also acquired at
each time point using a previously developed smartphone-based PpIX dosimeter to qualitatively
verify the location and intensity of fluorescence accumulation [9].
2.5.

Pre-clinical in vivo human measurements

Human skin measurements were performed on four healthy adult volunteers who gave informed
consent to participate in the study following a protocol approved by the Dartmouth College
Institutional Review Board. Measurements were taken on the underside of the forearm with the
palm facing up. A site for ALA gel application was demarcated using a rectangular piece of
black tape with a 10 mm diameter circular region cut out. The tissue regions on the forearm just
outside the tape were used as control sites and were also sampled at each time point. A 10%
ALA gel (Ameluz, Biofontera Inc., Massachusetts) was applied to the inside the taped region of
the forearm and allowed to dry in open air for 10 min, after which the first measurement was
taken. Subsequent measurements were taken at 60, 180, and 240 min time points, with the site
remaining covered from light exposure between measurements using a layer of plastic wrap and
an additional layer of black tape.
The 5mm FOV attachment (same as the murine measurements) was utilized with fixed
acquisition settings of 100 ms and 2300 ISO speed. Measurements were taken in ambient room
lighting and by repeatedly bringing the device in contact with the skin and holding for 2-3 s.
This was done three times at tissue sites outside the taped region and three times inside the taped
region, with the maximum intensity reading recorded and used for analysis. Differences in mean
intensity between the taped application region and control sites at each time point were compared
using a paired t-test. Widefield fluorescence images were also acquired at each time point using a
previously developed smartphone-based PpIX dosimeter [9].
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Results

Figure 3 shows the transmission spectra for the smartphone LED flash overlaid on the absorption
and fluorescence spectra of PpIX. The LED light source spans most of the visible spectrum
(430 to 750 nm), although notably the LED spectra does not extend to the 405 nm Soret band
peak excitation wavelength for PpIX. Therefore, the excitation cut-on and cut-off wavelengths
were determined to be approximately 440 to 560 nm, with a ≥600 nm longpass as the emission
filter. The optical power of the unfiltered LED was 45 mW/cm2 when the flash was in direct
contact with the power meter and 7 mW/cm2 passing through the angled flash channel to a 18
mm diameter circular sample plane.

Fig. 3. Transmission spectra of smartphone flash LED overlaid on absorption and fluorescence spectra of PpIX. Proposed excitation and emission filter ranges to utilize the phone
LED and camera sensor are highlighted.

Figure 4 contains spectra for three optical filter sets with adequate blocking OD for PpIX
detection. All three filter options achieved separabililty of excitation and emission wavelengths
with OD≥4 in the PpIX fluorescence window. Peak transmission was substantially higher for
glass filtering components than for gel filters (99% vs 40%), although when used in tandem the
glass filter set had a lower blocking OD for rejection of the flash LED and therefore a higher
noise floor (OD 4.6 vs 5.5 for glass and gel filters, respectively). Several other excitation gel
filter options with higher transmission were also evaluated, but none of them achieved sufficient
blocking OD to ensure adequate rejection of background signal to detect faint PpIX fluorescence
signals (data not shown).
Figure 5 demonstrates the CFCam app user interface controls and real-time signal quantification
functionality. When launched, the app is initialized with a live preview of the ultrawide camera
feed with a 200 × 200 pixel ROI overlaid to indicate the region from which average intensity is
calculated (Fig. 5(a)). A lock icon toggles the acquisition setting controls for camera sensor,
exposure, ISO speed, and LED brightness. Figure 5(b) provides screenshots of real-time intensity
calculation for attachments with 30 mm, 18 mm, and 5 mm diameter sampling FOV.
Figure 6 provides linear regression results from serial dilution of PpIX in 1% intralipid
phantoms across five different attachment versions. Optical power delivered to the sampling plane
varied based on the filter selection and ranged between 0.1 to 2.0 mW/cm2 , with the lowest/highest
throughputs being the small FOV gel filter and glass filter attachments, respectively; however, the
material cost of the glass filters attachment was $ 250 USD compared to under $1 for gel filters
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Fig. 4. Transmission spectra and blocking efficiency of three filter sets evaluated with
the proposed fluorescence attachment: (a-b) glass filters, (c-d) red/green gel filters, (e-f)
blue/green gel filters.

Fig. 5. CFCam smartphone app user interface for control of acquisition parameters and
real-time fluorescence intensity quantification. (a) Labeled screenshot of app user interface.
(b) Screenshots of real-time intensity calculation for attachments with 30 mm, 18 mm, and
5 mm sample plane field-of-view diameter.

(Dataset 1, Ref. [35]). Despite these differences in optical efficiency, signal linearity from 10 to
1000 nM was excellent (R2 >0.99) for both glass filter and gel filter attachments.
Figure 7 contains results from in vivo pre-clinical measurements of ALA-induced PpIX
fluorescence in animal and human skin. No fluorescence accumulation was observed at the 10
min post-application of the ALA gel. At 60 min post-ALA gel application, however, a statistically
significant increase in normalized fluorescence intensity was observed in both murine and human
subjects (control vs ALA gel, mice: 3.75 vs 1.04, p<0.05; human: 1.33 vs 1.09, p<0.05). The
PpIX fluorescence accumulation further increased at the 180 min time point, with some systemic
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different attachment versions with varying filtering components and sampling field-of-view.
Left: image of assembled attachment. Middle: linear scatter plot of normalized intensity
measurements. Error bars indicate ± one standard deviation from the mean based on three
repeat measurements. Right: Log-log plot of measured intensities averaged across all
replicates with linear regression fit overlaid.
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PpIX production detected at the control site in the murine measurements (control vs ALA gel,
mice: 11.6 vs 5.21, p<0.01; human: 2.01 vs 1.10, p<0.05). Visualization 2 provides a video
demonstration of an in vivo measurement being taken at both control and ALA gel sites on the
forearm of a healthy adult volunteer.

Fig. 7. In vivo measurement of PpIX fluorescence using smartphone system in mice and
human skin after application of aminolevulinic (ALA) gel. (a and d) Annotated white light
images of experimental setup. In mice, ALA gel was applied to the right leg and mid-back
of the mouse and the left leg was used as a control imaging site. In humans, black tape
with a circular cutout was used to demarcate the application site on the forearm. (b and e)
Widefield fluorescence images acquired with a secondary imaging system [9] to confirm
PpIX fluorescence accumulation over time. (c and f) Mean intensity of control and ALA
sites measured at each time point using the proposed ultracompact smartphone system. Error
bars indicate ± one standard deviation from the mean based on three repeat measurements.
Statistical significance testing was performed using a paired t-test at each time point. The
following symbols indicate p-value results as follows: ns (P>0.05), *(P≤0.05), **(P≤0.01).

4.

Discussion

In recent years, there has been robust growth in the development of smartphone-based imaging
systems for biomedical imaging applications [21,22]. However, the degree to which the native
optics are leveraged varies greatly from application to application, and the addition of more
complex active optics to the phone simply reduces the potential for wider adoption. In this
study, an ultracompact attachment design was developed, which leverages the on-board optics
for quantitative measurement of PpIX fluorescence in skin. The key features used were (1)
exploitation of green wavelengths for PpIX excitation fitting with the available spectrum of the
flash, and (2) use of the ultrawide camera lens, which provided good signal quantification at a
short working distance.
The compactness and capability for real-time signal quantification of the system give it
high potential to be utilized in dermatological settings for monitoring and personalization of
PDT treatment regimens or measurement of PpIX in other clinical settings such as wound
assessment [39,40], lesion identification [41,42], porphyria [43,44]. In intralipid phantoms, the
system achieved excellent linearity down to 10 nM, and was able to detect PpIX fluorescence
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accumulation in both murine and human skin. This sensitivity is similar to a previously developed
system by Ruiz et al. [9] which utilized a 405nm LED ring for Soret peak excitation, but also
had a larger working distance of 72mm. We hypothesize that the limit of detection of this short
working distance attachment could be further improved if an external 405nm LED was utilized
in place of filtering the built-in flash LED, but with the trade-off of significantly increasing the
cost/complexity of the design. The proposed attachment was <30 cm3 in volume and had an
insignificant material cost of less than $1 USD when implemented with lighting gel filters.
While the attachment models in this study were specific to the Apple iPhone 12, the model
design can be readily adapted to any smartphone model by adjusting the attachment layout using
computer aided design software. The proposed attachment was designed for contact-based
sampling of the skin. This approach is helpful for fluorescence measurement in two important
ways: 1) shielding the measurement from external room lighting and 2) ensuring consistent
sampling with regards to field of view and distance. A variety of attachment designs with sampling
field of view ranging from 5 to 30 mm were demonstrated in this study. In dermatological
applications, these relatively small fields of view can facilitate easier sampling of moderately
curved tissues (for example, near the cheek bones and eyes). Additionally, this sampling field
of view can readily be modified in the 3D printed design to suit various applications. The
system’s hardware and software design are both publicly available and can be adapted for other
contact-based fluorescence intensity measurement applications. This open-source, modular
design provides proof of principle for integrating optical filters with the cameras and light sources
native to smartphones in order to achieve sensitive fluorescence quantification.
There are limitations of the present study as well as areas for further improvement of this
ultracompact design. Although the proposed system should be feasible for any smartphone system
with an LED flash and camera, the current software for real-time analysis is only compatible
with iOS devices. Additionally, the 10-bit video frame analysis routine only provides relative
intensity information and would need to be calibrated for each camera sensor in order to provide
absolute quantification across multiple phone models. The pre-clinical measurements were only
performed on small sample sizes as a proof of principle for demonstrating its capability for in
vivo measurements. For human clinical use, there may be additional factors which could impact
background fluorescence signatures (diet, metabolism, and skin pigmentation, for example).
Although the amount of topical gel applied to both murine and human tissues was similar,
an increase in PpIX fluorescence was observed at 180 min, whereas no increase in control
fluorescence was observed in humans (Fig. 7(c) and 7(f)). We hypothesize that this differential
increase in background fluorescence was a result of systemic ALA uptake and PpIX production
due to the thin dermal tissue layer and much higher metabolic rate of the mice. Further work
is needed characterize the impact of these factors in order to establish robust intrasubject PpIX
fluorescence quantification. Further work to translate this system into clinical trials and evaluate
the utility in the hands of non-technical team members is ongoing.
In conclusion, a simple passive attachment was prototyped and tested for use with a smartphone,
to allow quantification of PpIX with the native opto-electronics on the device. The use of gel
filters and 3D printed clip-on design result in an ultracompact, handheld fluorescence sensing
platform, with green wavelength band excitation and red wavelength emission. The detection
threshold was sufficient to detect biologically relevant PpIX levels in both mice and human
skin, and the temporal kinetics of production were followed. The device design and software
prototype are available as an open-source project on GitHub, to allow further testing and use of
this translatable approach by other laboratories.
Funding. National Cancer Institute (P01 CA084203).
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